74例咽喉反流患者抗反流黏膜切除术后2年临床疗效分析

doi:10.6040/j.issn.1673-3770.0.2024.185

摘要/Abstract

摘要： 目的探索内镜下抗反流黏膜切除术(anti-reflux mucosectomy, ARMS)治疗咽喉反流性疾病(laryngopharyngeal reflux disease, LPRD)术后2年的临床疗效。方法回顾性分析行ARMS手术并有随访结果的患者资料221例,所有患者通过口咽pH监测诊断LPRD,对比术前及术后2年的反流症状指数量表(reflux symptom index, RSI)、24hDx-pH监测结果,研究ARMS对LPRD的疗效,并以胃食管阀瓣(gastroesophageal flap valve, GEFV)级别分组,探讨GEFV对ARMS疗效的影响。结果 221例中共有74例患者纳入研究。RSI评分较术前降低(P=0.005),其中声嘶/发音障碍、持续清嗓、吞咽食物、水或药片不利、烧心、胸痛、胃痛好转最为明显(P=0.013,0.04,0.043,0.02)。Dx-pH监测结果,立位Ryan指数较术前降低(P<0.001)。GEFV Ⅰ、Ⅱ级患者术后立位Ryan指数较术前明显好转(P<0.05),卧位Ryan指数较术前无明显变化(P>0.05)。阀瓣Ⅲ、Ⅳ级患者术后立位Ryan指数、卧位Ryan指数均较术前无明显变化(P>0.05)。结论 ARMS手术可有效改善LPRD,阀瓣分级对判断预后有意义,Ⅰ、Ⅱ级患者症状改善尤其明显,阀瓣Ⅲ、Ⅳ级患者手术效果不明显。

关键词: 抗反流黏膜切除术, 咽喉反流性疾病, 阀瓣分级, Ryan指数, Dx-pH监测

Abstract: Objective To evaluate the two-year clinical efficacy of endoscopic anti-reflux mucosectomy(ARMS)in the treatment of laryngopharyngeal reflux disease(LPRD). Methods A retrospective analysis was performed on 221 patients who underwent ARMS and had available follow-up data. All patients were diagnosed with LPRD by oropharyngeal pH monitoring. Comparisons were made between pre-operative and two-year post-operative Reflux Symptom Index(RSI)scores and 24-hour Dx-pH monitoring results to assess the efficacy of ARMS in the treatment of LPRD. Patients were also grouped by gastroesophageal valve(GEFV)grade to investigate the influence of GEFV on ARMS efficacy. Results 74 out of 221 patients were included in the study. RSI scores decreased significantly compared to preoperative values(P=0.005), with the most notable improvements observed in hoarseness/voice disorders, persistent throat clearing, difficulty swallowing food, liquids or pills, heartburn, chest pain and stomach pain(P=0.013, 0.04, 0.043, 0.02). According to the Dx-pH monitoring, the upright Ryan score decreased significantly compared to preoperative values(P<0.001). Patients with GEFV grades Ⅰ and Ⅱ showed a significant improvement in Ryan scores in the upright position postoperatively(P<0.05), while no significant changes were observed in Ryan scores in the supine position(P>0.05). In patients with GEFV grades Ⅲ and Ⅳ, no significant changes were observed in either the upright or supine Ryan scores postoperatively(P>0.05). Conclusion ARMS can effectively improve symptoms of LPRD and GEFV grading is valuable in predicting prognosis. Patients with GEFV grades Ⅰ and Ⅱ show significant symptom improvement, whereas patients with GEFV grades Ⅲ and Ⅳ show limited surgical benefit.

Key words: Anti-reflux Mucosectomy, Laryngopharyngeal Reflux Disease, Gastroesophageal Flap Valve Grading, Ryan Index, Dx-pH Monitoring

中图分类号:

R766.14

张斌,陈升,李冰,席晓宇,钟长青,高晓佩,李连勇,隋昕珂. 74例咽喉反流患者抗反流黏膜切除术后2年临床疗效分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 120-125.

ZHANG Bin, CHEN Sheng, LI Bing, XI Xiaoyu, ZHONG Changqing, GAO Xiaopei, LI Lianyong, SUI Xinke. Analysis of the two-year clinical effectiveness of anti-reflux mucosectomy in 74 patients with laryngopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 120-125.

参考文献

[1] 中华耳鼻咽喉头颈外科杂志编辑委员会咽喉组, 中华医学会耳鼻咽喉头颈外科学分会咽喉学组, 中华医学会耳鼻咽喉头颈外科学分会嗓音学组. 咽喉反流性疾病诊断与治疗专家共识(2022年,修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(10): 1149-1172. doi:10.3760/cma.j.cn115330-20220711-00428
[2] Masaany M, Marina MB, Sharifa Ezat WP, et al. Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux[J].J Laryngol Otol,2011,125(5):502-508. doi:10.1017/S0022215111000120
[3] Jin BJ, Lee YS, Jeong SW, et al. Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients[J]. Laryngoscope, 2008, 118(5): 938-941. doi:10.1097/MLG.0b013e3181651c3a
[4] Wei CH. A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux[J]. Eur Arch Otorhinolaryngol, 2016, 273(11): 3795-3801. doi:10.1007/s00405-016-4142-y
[5] Anzi c SA, Turkalj M, Župan A, et al. Eight weeks of omeprazole 20 Mg significantly reduces both laryngopharyngeal reflux and comorbid chronic rhinosinusitis signs and symptoms: Randomised, double-blind, placebo-controlled trial[J]. Clin Otolaryngol, 2018, 43(2): 496-501. doi:10.1111/coa.13005
[6] van der Westhuizen L, von SJ, Wilkerson BJ, et al. Impact of Nissen fundoplication on laryngopharyngeal reflux symptoms[J]. Am Surg, 2011, 77(7): 878-882. doi:10.1177/000313481107700723
[7] Zhang C, Hu ZW, Yan C, et al. Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale[J]. World J Gastroenterol, 2017, 23(19): 3546-3555. doi:10.3748/wjg.v23.i19.3546
[8] Suzuki T, Seki Y, Okamoto Y, et al. Hypopharyngeal multichannel intraluminal impedance leads to the promising outcome of antireflux surgery in Japanese population with laryngopharyngeal reflux symptoms[J]. Surg Endosc, 2018, 32(5): 2409-2419. doi:10.1007/s00464-017-5940-z
[9] Morice D, Elhassan HA, Myint-Wilks L, et al. Laryngopharyngeal reflux: is laparoscopic fundoplication an effective treatment?[J]. Ann R Coll Surg Engl, 2022, 104(2): 79-87. doi:10.1308/rcsann.2021.0046
[10] Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study[J]. Ann Gastroenterol, 2014, 27(4): 346-351
[11] Sui XK, Gao XP, Zhang L, et al. Clinical efficacy of endoscopic antireflux mucosectomy vs. Stretta radiofrequency in the treatment of gastroesophageal reflux disease: a retrospective, single-center cohort study[J]. Ann Transl Med, 2022, 10(12): 660. doi:10.21037/atm-22-2071
[12] Yoo IK, Ko WJ, Kim HS, et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study[J]. Surg Endosc, 2020, 34(3): 1124-1131. doi:10.1007/s00464-019-06859-y
[13] Ayazi S, Lipham JC, Hagen JA, et al. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold[J]. J Gastrointest Surg, 2009, 13(8): 1422-1429. doi:10.1007/s11605-009-0915-6
[14] Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations[J]. Gastrointest Endosc, 1996, 44(5): 541-547. doi:10.1016/s0016-5107(96)70006-8
[15] Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index(RSI)[J]. J Voice, 2002, 16(2): 274-277. doi:10.1016/s0892-1997(02)00097-8
[16] Li JJ, Zhang LH, Zhang CF, et al. Linguistic adaptation, reliability, validation, and responsivity of the Chinese version of reflux symptom index[J]. J Voice, 2016, 30(1): 104-108. doi:10.1016/j.jvoice.2013.12.006
[17] Gelardi M, Silvestri M, Ciprandi G, et al. Correlation between the reflux finding score and the reflux symptom index in patients with laryngopharyngeal reflux[J]. J Biol Regul Homeost Agents, 2018, 32(1 Suppl. 2): 29-31
[18] Hedberg HM, Kuchta K, Ujiki MB. First experience with banded anti-reflux mucosectomy(ARMS)for GERD: feasibility, safety, and technique(with video)[J]. J Gastrointest Surg, 2019, 23(6): 1274-1278. doi:10.1007/s11605-019-04115-1
[19] 侯波, 梁程程, 魏东敏, 等. 耳鼻咽喉门诊咽喉良性病变老年患者喉镜观察与嗓音声学分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 20-25. doi:10.6040/j.issn.1673-3770.1.2020.111 HOU Bo, LIANG Chengcheng, WEI Dongmin, et al. Laryngoscopy observation and voice acoustic analysis of elderly patients with benign laryngopharyngeal lesions in an ENT out-patient clinic[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 20-25. doi:10.6040/j.issn.1673-3770.1.2020.111
[20] 王磊, 李保卫, 王刚, 等. 阻塞性睡眠呼吸暂停低通气综合征患者夜间碱反流初步研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 75-79, 92. doi:10.6040/j.issn.1673-3770.0.2022.138 WANG Lei, LI Baowei, WANG Gang, et al. A preliminary study on nocturnal alkali reflux in OSAHS patients[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 75-79, 92. doi:10.6040/j.issn.1673-3770.0.2022.138
[21] 曾宪廷, 王广科, 孙占伟, 等. 伴咽喉反流的难治性鼻窦炎术后应用质子泵抑制剂的疗效观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512 ZENG Xianting, WANG Guangke, SUN Zhanwei, et al. Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512
[22] 黄靖, 徐媚, 罗伟, 等. 南京市居民咽喉返流疾病的流行病学调查分析[J]. 中国耳鼻咽喉颅底外科杂志, 2013, 19(5): 416-419. doi:10.11798/j.issn.1007-1520.201305008 HUANG Jing, XU Mei, LUO Wei, et al. Epidemiological investigation and analysis of laryngopharyngeal reflux disease in residents of Nanjing City[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2013, 19(5): 416-419. doi:10.11798/j.issn.1007-1520.201305008
[23] 邹哲飞, 陈伟, 袁琨,等.武汉市咽喉反流性疾病流行病学研究[J].听力学及言语疾病杂志. 2018, 26(6): 638-641 ZOU Zhefei, CHEN Wei, YUAN Kun, et al. Epidemiological Study of Laryngopharyngeal Reflux Disease in Wuhan[J]. Journal of Audiology and Speech Pathology, 2018, 26(6): 638-641
[24] Lechien JR, Mouawad F, Barillari MR, et al. Treatment of laryngopharyngeal reflux disease: a systematic review[J]. World J Clin Cases, 2019, 7(19): 2995-3011. doi:10.12998/wjcc.v7.i19.2995
[25] Lechien JR, Dapri G, Dequanter D, et al. Surgical treatment for laryngopharyngeal reflux disease: a systematic review[J]. JAMA Otolaryngol Head Neck Surg, 2019, 145(7): 655-666. doi:10.1001/jamaoto.2019.0315
[26] Ward MA, Ebrahim A, Kopita J, et al. Magnetic sphincter augmentation is an effective treatment for atypical symptoms caused by gastroesophageal reflux disease[J]. Surg Endosc, 2020, 34(11): 4909-4915. doi:10.1007/s00464-019-07278-9
[27] Liang WT, Wu JM, Hu ZW, et al. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency[J]. Minerva Chir, 2014, 69(3): 121-127
[28] Gao X, Wang ZG, Wu JM, et al. Radiofrequency treatment on respiratory symptoms due to gastroesophageal reflux disease[J]. Chin Med J, 2011, 124(7): 1006-1009
[29] Trad KS, Turgeon DG, Deljkich E. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms[J]. Surg Endosc, 2012, 26(3): 650-660. doi:10.1007/s00464-011-1932-6
[30] El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies[J]. Aliment Pharmacol Ther, 2010, 32(6): 720-737. doi:10.1111/j.1365-2036.2010.04406.x
[31] Brar TS, Draganov PV, Yang D. Endoluminal therapy for gastroesophageal reflux disease: in between the pill and the knife?[J]. Dig Dis Sci, 2017, 62(1): 16-25. doi:10.1007/s10620-016-4355-3

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed